Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences 27-28 Ordibehesht.

Slides:



Advertisements
Similar presentations
 Most common and important degenerative disease of the brain  Shrinkage in size and weight of the brain  Severe degree of diffuse cerebral atrophy.
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Alzheimer’s Disease Edwin Onattu P. 3.
Etiopathogenesis of Alzheimer's disease
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Frontotemporal Dementia
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
MECHANISMS OF AGING TheoryPrinciples DNA & Genetic Theory Aging is predetermined by genetic programming. Neuroendocrine Theory Loss of hypothalamic regulation.
Dementia with Lewy Bodies
DEMENTIA By: Angela Pabon. What is Dementia? Dementia does not always mean that one has Alzheimer's disease, there are over 80 forms of dementia The definition.
Alzheimer’s Disease: Genetics, Pathogenesis, Models, and Experimental Therapeutics.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
Dr. Amr Moustafa Biochemistry Unit Department of Pathology.
AGING AND TRAUMA Key Points Increased longevity results in increased neurological disorders ‘Normal’ age-related changes in brain structure Neurodegenerative.
Middle and Old Age. Maximum Recorded Life Spans Human Indian Elephant Gorilla Common Toad Domestic Cat Domestic Dog Vampire Bat House Mouse
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.
Understanding the Person with Dementia Oxford Brookes University What is dementia? How do we diagnose it? What can we do? Sharon Christie OPTIMA, University.
Chapter 15 - Cognitive Disorders I.Delirium Acute, temporary impairment in perception & cognition Fluctuating course.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Dementia syndrome.
Methodological Issues 4 Age effects - the consequence of being a given chronological age 4 Cohort effects - the consequences of having been born in a given.
Biological Myths of Aging Memory declines drastically with age for all people. IQ declines drastically with age in all people. Learning becomes more difficult.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Non-Alzheimer’s Dementias
Amnesia Syndromes Lesson 22. Wernicke-Korsakoff’s Syndrome n Deficits similar to H.M. l Anterograde l retrograde more severe n Cause: Long-term alcohol.
1 TOPIC 13 COGNITIVE DISORDER.  Dissociative disorder involve changes or disturbances in identity, memory or consciousness that affect the ability to.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Delirium and Dementia.
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
NEUROCOGNITIVE DISORDERS
Dr. Usman Ghani CNS Block.  Pathophysiology of alzheimer’s disease: 5I.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
CU-1 Summary of Neuropathological and Clinical Features of PDD Clive Ballard, MD Professor of Age Related Diseases Institute of Psychiatry King’s College.
HOW TO EXAMINE PATIENTS WITH DEMENTIA Serge Gauthier, MD, FRCPC McGill Centre for Studies in Aging Douglas Mental Health Research Institute.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
Epidemiology of Alzheimer’s Disease
Under the supervision of miklós jászberényi
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Dementia Nicholas Cascone, PA-C.
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Alzheimer’s Disease: Advances and Hope Trey Sunderland, M.D. Chief, Geriatric Psychiatry Branch National Institute of Mental Health Bethesda, Maryland.
Alzheimer’s Disease (AD)
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Anne Moore Specialist in Special Care NHS Lanarkshire PDS
Dementia with Lewy Bodies
Rosa Maria Moresco University of Milan Bicocca
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Dementia: from molecules to minds
Alzheimer’s Disease CNS Block.
How Does Dementia Affect the Brain and it’s Cognitive Processes
Imaging AD Progression Amyloid Imaging Agents.
65 year-old female with Alzheimer’s disease
Cognitive Disorders and Aging
Alzheimer Disease Mayo Clinic Proceedings
Amnesia Syndromes Lecture 21.
Dementia Supischa Theerasasawat Eric Pfeiffer, M.D J. Wesson Ashford
Chapter 30 Delirium and Dementia
Probing the Biology of Alzheimer's Disease in Mice
PowerPoint made by: Monique Johnson
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Presentation transcript:

Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht 1392 April 16-17, 2013

Dementing Illnesses: Proteinopathies DAT: beta amyloid => posterior cortex (parietal / temporal) FTD: tau => anterior cortex (frontal / temporal) DLB: alpha synuclein => limbic system / midbrain / brain stem / cortex

Neuritic Plaques

Neurofibrillary Tangles

Evidence for Beta Amyloid as the Putative Toxic Agent in DAT The clinical phenotype of AD corresponds to impairment in brain regions with the highest plaque burdens The degree of intellectual impairment in AD directly correlates with AB plaque burden Beta amyloid deposition is associated with inflammatory changes in the cerebral cortex including cell death Most cases of familial AD are caused by mutations in genes regulating expression of presenilin DAT occurs uniformly in patients with Down’s syndrome (trisomy 21) at an early age

DAT: Distribution of Neuritic Plaques

DAT: Distribution of NFT

Dement Geriatric Cogn Disord 2001; 12: Coronal Image of the Brain of an Older Adult with Normal Cognition

Dement Geriatric Cogn Disord 2001; 12: Brain MRI Images of Older adults with a) Alzheimer’s Disease b) Normal Cognition and c) DLB

Flurodeoxyglucose (FDG) PET normal DAT

Metabolism of the Amyloid Precursor Protein Beta Secretase Cleavage Site Alpha Secretase Cleavage Site 17 Gamma Secretase Cleavage Site A Beta domain Amyloid Precursor Protein Cell membrane Gamma Secretase

Proteolytic Cleavages of APP to Produce A  Peptide Selkoe DJ et al. JAMA. 2000;283:  -amyloid precursor protein  -secretase A  peptide  -secretase Extracellular space TMCytoplasm COOH NH 2

Proteolysis of the APP 1.APP + alpha secretase + gamma secretase = P3 (soluble) APP + beta secretase + gamma secretase = AB (insoluble)

Dementia of Lewy Body Dementia with Lewy bodies overlaps clinically with Alzheimer’s disease and Parkinson’s Disease. DLB often has a rapid or acute onset, with especially rapid decline in the first few months. DLB tends to progress more quickly than Alzheimer’s disease. fluctuating cognition with great variations in attention and alertness from day to day and hour to hour, recurrent visual hallucinations (observed in 75% of people with DLB), and motor features of Parkinson's. Suggestive symptoms are REM-sleep behavior disorder. hypersensitivity to neuroleptic and antiemetic medications

DLB

Differential Diagnosis

Vascular Dementia Dementia caused by problems in supply of blood to the brain, typically by a series of minor stroke. Was previously referred to as "multi-infarct dementia” Vascular dementia is the second most common form of dementia after Alzheimer’s Disease (AD) in older adults. Presents with cognitive impairment, acutely or subacutely, after an acute cerebrovascular event. After the onset a stepwise progression is typical.

Vascular Dementia

Who can suggest the next case!?

Dementia Due to Head Trauma